sodium nitroprusside Concentrate 50 mg / 2mL Injection 2 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 70436-0028-80 |
|---|---|
| Product NDC | 70436-0028 |
| Generic Drug Name | sodium nitroprusside Concentrate |
| Brand Name | sodium nitroprusside |
| Manufacturer | Slate Run Pharmaceuticals, LLC |
| Strength | 50 mg / 2mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial |
| Package Description | 1 VIAL in 1 CARTON (70436-028-80) / 2 mL in 1 VIAL |
| Active Ingredients | Sodium Nitroprusside |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
sodium nitroprusside Concentrate 50 mg / 2mL Injection is tracked under NDC 70436-0028-80 and rolls up into product family 70436-0028. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Vial.
- Manufacturer: Slate Run Pharmaceuticals, LLC.
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
sodium nitroprusside Concentrate 50 mg / 2mL Injection 2 mL, NDC 70436-0028-80, is a Slate Run Pharmaceuticals, LLC 50 mg / 2mL injection presentation packaged as 1 Vial.
NDC search formats
- Canonical NDC 11: 70436-0028-80.
- Digits-only NDC 11: 70436002880.
- Possible 10-digit display format: 70436-028-80 (7043602880).
Helpful product links
- Search by brand name: sodium nitroprusside.
- Exact NDC 11: 70436-0028-80.
- Product family NDC: 70436-0028.
